Category: Sleep Health

Sleep Health

Latest

Semaglutide Associated With Lower Incidence of OSA in Post Hoc Analysis

A post hoc analysis of the SELECT trial suggests that semaglutide 2.4 mg is associated with a significantly lower incidence of obstructive sleep apnea in adults with overweight or obesity and established cardiovascular disease. While these findings are promising, Novo Nordisk notes that semaglutide is not currently approved to treat obstructive sleep apnea and further research is required.

Parameters

Latest

Findings Question Real-World Compatibility of Sleep, Exercise Recommendations

A study of 28 million days of health data reveals that fewer than 13% of individuals consistently meet both sleep and physical activity guidelines, suggesting that high-quality sleep is a primary driver of next-day movement. The findings indicate that prioritizing sleep may be a more effective strategy for increasing daily activity than the reverse.